Meditech CEO leaves, chair steps down

By Melissa Trudinger
Friday, 30 July, 2004

Meditech (ASX: MTR) is looking for a new CEO as CEO Chris Carter steps down, three months after a shareholder stoush forced his resignation from the company.

The problems arose at Meditech's AGM in late April, where Carter was due to stand for re-election to the board of directors. Slightly more than half of the proxy votes lodged, which represented about 12 per cent of all shareholders, voted against re-election, forcing Carter to withdraw his nomination and hand in his notice of resignation.

The stoush has also resulted in Bob Moses stepping down from his position as chairman of Meditech's board of directors, although he will remain a non-executive director for the time being. Richard Fox, former chairman of the company and a current director will take over as interim chairman.

According to a recent shareholder update from Moses, candidates for CEO are being interviewed at present, and a decision is likely to be announced shortly.

Related News

Preventing neural graft rejection in Parkinson's patients

Researchers have engineered a way to fool the immune system into accepting neural grafts as part...

Retinal health linked to dementia risk, study shows

Researchers have discovered that the blood vessels at the back of the eye — called retinal...

Pancreatic cancer hijacks metabolism switch to help it spread

Pancreatic cancer hijacks a molecule known for regulating physiological processes, such as food...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd